Skip to content

Advertisement

BMC Cancer

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Cytotoxicity and infiltration of human NK cells in in vivo-like tumor spheroids

  • Ariane Giannattasio1,
  • Sandra Weil1,
  • Stephan Kloess2,
  • Nariman Ansari3,
  • Ernst H K Stelzer3,
  • Adelheid Cerwenka4,
  • Alexander Steinle5,
  • Ulrike Koehl2 and
  • Joachim Koch1Email author
Contributed equally
BMC Cancer201515:351

https://doi.org/10.1186/s12885-015-1321-y

Received: 4 December 2014

Accepted: 17 April 2015

Published: 3 May 2015

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
4 Dec 2014 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Reviewed Reviewer Report
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
Reviewed Reviewer Report
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
17 Apr 2015 Editorially accepted
3 May 2015 Article published 10.1186/s12885-015-1321-y

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
NK Cell Biology, Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy
(2)
Institute for Cellular therapeutics, IFB-Tx, Hannover Medical School
(3)
Physical Biology Group, Buchmann Institute for Molecular Life Sciences, Goethe Universität
(4)
Innate Immunity, German Cancer Research Center
(5)
Institute for Molecular Medicine, Johann Wolfgang Goethe-University

Advertisement